TDC
FLGT icon

Thompson Davis & Co’s Fulgent Genetics FLGT Stock Holding History

Thompson Davis & Co’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$34K Sell
8,650
-4,734
-35% -$20.3K 0.07% 257
2018
Q2 		$55K Sell
13,384
-2,448
-15% -$9.7K 0.13% 172
2018
Q1 		$63K Sell
15,832
-19,402
-55% -$85.4K 0.17% 133
2017
Q4 		$154K Buy
+35,234
New +$135K 0.36% 64

Other funds holding FLGT

OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $5.31B AUM 25.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Thompson Davis & Co's FLGT Position: Q3 2018 in Review

Thompson Davis & Co reduced its Fulgent Genetics (FLGT) stake by 35% in Q3 2018, selling an estimated $20.3K and leaving 8,650 shares worth $34K. The position accounts for 0.07% of the portfolio, ranked #257.

Thompson Davis & Co first reported a position in FLGT in Q4 2017 and has held it in 4 quarters since. The position peaked at $154K in Q4 2017. 17 funds tracked by Wall St. Rank hold FLGT as of Q3 2018.

  • Thompson Davis & Co held 8,650 shares of Fulgent Genetics worth $34K as of Q3 2018.
  • Thompson Davis & Co sold 4,734 Fulgent Genetics shares in Q3 2018, an estimated $20.3K.
  • Fulgent Genetics made up 0.07% of Thompson Davis & Co's portfolio in Q3 2018, its #257 holding.
  • Thompson Davis & Co first reported a position in Fulgent Genetics in Q4 2017 and has held it in 4 quarters since.
  • Thompson Davis & Co's Fulgent Genetics position peaked at $154K in Q4 2017.
  • 17 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.